Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950138-19-000323
Filing Date
2019-05-24
Accepted
2019-05-24 08:13:30
Documents
2
Period of Report
2019-05-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1573
2 POWER OF ATTORNEY FOR CARLOS V. PAYA payapoa_052019.txt EX-24 3577
  Complete submission text file 0000950138-19-000323.txt   6544
Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1227
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Paya Carlos V (Reporting) CIK: 0001606244 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35803 | Film No.: 19852069